This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignees: University of Pennsylvania, Val-Chum, Limited Partnership. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 2,659 
1 out of 20 Years Active: 2025
Title: Shilei Ding: Innovator in HIV-1 Treatment
Introduction
Shilei Ding is a notable inventor based in California, recognized for his contributions to the field of HIV-1 treatment. His innovative work focuses on developing small molecules that enhance the effectiveness of antibody-dependent cellular cytotoxicity in HIV-1 infected cells.
Latest Patents
Ding holds a patent for "Small molecules that sensitize HIV-1 infected cells to antibody dependent cellular cytotoxicity." This patent provides compounds and methods for treating HIV-1 in humans infected with the virus or for preventing infection in those susceptible to it. The compounds are defined by specific formulas, and the methods involve administering therapeutically effective amounts of these compounds to patients.
Career Highlights
Throughout his career, Shilei Ding has worked with prestigious institutions, including the University of Pennsylvania and Val-Chum, Limited Partnership. His research has significantly contributed to advancements in HIV treatment methodologies.
Collaborations
Ding has collaborated with notable colleagues, including Melissa Carey Davies and Amos B. Smith III. Their combined expertise has furthered research in the field of HIV-1 treatment.
Conclusion
Shilei Ding's innovative work in developing compounds for HIV-1 treatment showcases his dedication to improving healthcare outcomes. His contributions are vital in the ongoing fight against HIV-1, and his patent reflects a significant advancement in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile